Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 54624-57-6 | MDL No. : | MFCD00160009 |
Formula : | C7H5BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PHPYXVIHDRDPDI-UHFFFAOYSA-N |
M.W : | 197.03 | Pubchem ID : | 2776281 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.79 |
TPSA : | 28.68 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.88 cm/s |
Log Po/w (iLOGP) : | 1.33 |
Log Po/w (XLOGP3) : | 2.28 |
Log Po/w (WLOGP) : | 2.33 |
Log Po/w (MLOGP) : | 1.75 |
Log Po/w (SILICOS-IT) : | 2.75 |
Consensus Log Po/w : | 2.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.16 |
Solubility : | 0.135 mg/ml ; 0.000685 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.52 |
Solubility : | 0.596 mg/ml ; 0.00302 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.77 |
Solubility : | 0.0337 mg/ml ; 0.000171 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | Reflux | The schematic representation of the synthesis of LHAc is given in Scheme 1. First, 2-bromobenzimidazole was obtained from 2-mercaptobenzimidazole by the reported method [13]. In the nextstep, 2-bromobenzimidazole (1.97 g, 0.01 mol) was refluxed in20 mL of 80percent hydrazine hydrate solution, to obtain 2-Hydrazinobenzimidazole (1.35 g, Yield: 91percent). Finally, diacetylmonoxime (1.01 g, 0.01 mol) was added to the 20 ml methanolicsolution of 2-hydrazinobenzimidazole (1.48 g, 0.01 mol) in presenceof 3 drops of glacial acetic acid. The resulting mixture wasrefluxed for 4 h. On cooling, the white crystals separated werefiltered and washed with cold methanol to get the desired product(1.6 g, yield: 55percent, M.P 240 C). |
91% | for 4 h; Reflux | The schematic representation of the synthesis of ligand is given in Scheme 1 . First, 2-bromobenzimidazole was obtained from 2-mercaptobenzimidazole by the reported method [24]. In the next step, 2-bromobenzimidazole (1.97g, 10mmol) was refluxed in 20.0mL of 80percent hydrazine hydrate solution, to obtain 2-hydrazinobenzimidazole (1.35g, Yield: 91percent) [25]. Finally, to the magnetically stirred methanolic solution of 2-hydrazinobenzimidazole (1.65g, 10.0mmol), hydroxyacetone (0.740g, 10.0mmol) in methanol was added dropwise. The mixture was refluxed on a water bath for 1h. The progress of the reaction was monitored by TLC. The buff colored precipitate formed was filtered and washed with cold methanol. The solid product was dried in vacuo for 4h. |
[ 50847-09-1 ]
2-Bromo-1H-imidazole-4,5-dicarbonitrile
Similarity: 0.76
[ 1388031-41-1 ]
2-Bromo-6-chloro-1H-benzo[d]imidazole
Similarity: 0.72
[ 791595-74-9 ]
5-Bromo-1H-benzo[d]imidazol-2-amine
Similarity: 0.69
[ 1388031-41-1 ]
2-Bromo-6-chloro-1H-benzo[d]imidazole
Similarity: 0.72
[ 17228-38-5 ]
N-Methyl-1H-benzo[d]imidazol-2-amine
Similarity: 0.71
[ 582-60-5 ]
5,6-Dimethyl-1H-benzo[d]imidazole
Similarity: 0.70